{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:34:12Z","timestamp":1782977652072,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:00:00Z","timestamp":1650672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T00:00:00Z","timestamp":1650672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-022-02613-z","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T15:03:33Z","timestamp":1650726213000},"page":"1991-1998","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association between diabetic nephropathy and left ventricular longitudinal myocardial function in type 1 diabetes mellitus patients with preserved ejection fraction"],"prefix":"10.1007","volume":"38","author":[{"given":"Eri","family":"Ota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayu","family":"Shono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Sumimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Urai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,23]]},"reference":[{"issue":"25","key":"2613_CR1","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","volume":"115","author":"S Boudina","year":"2007","unstructured":"Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115(25):3213\u20133223","journal-title":"Circulation"},{"issue":"11","key":"2613_CR2","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.echo.2011.07.017","volume":"24","author":"L Ernande","year":"2011","unstructured":"Ernande L, Bergerot C, Rietzschel ER, De Buyzere ML, Thibault H, Pignonblanc PG, Croisille P, Ovize M, Groisne L, Moulin P, Gillebert TC, Derumeaux G (2011) Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiogr 24(11):1268-1275e1261","journal-title":"J Am Soc Echocardiogr"},{"key":"2613_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1475-2840-12-84","volume":"12","author":"T Cognet","year":"2013","unstructured":"Cognet T, Vervueren PL, Dercle L, Bastie D, Richaud R, Berry M, Marchal P, Gautier M, Fouilloux A, Galinier M, Carrie D, Massabuau P, Berry I, Lairez O (2013) New concept of myocardial longitudinal strain reserve assessed by a dipyridamole infusion using 2D-strain echocardiography: the impact of diabetes and age, and the prognostic value. Cardiovasc Diabetol 12:84","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2613_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12933-015-0201-8","volume":"14","author":"Y Mochizuki","year":"2015","unstructured":"Mochizuki Y, Tanaka H, Matsumoto K, Sano H, Toki H, Shimoura H, Ooka J, Sawa T, Motoji Y, Ryo K, Hirota Y, Ogawa W, Hirata KI (2015) Clinical features of subclinical left ventricular systolic dysfunction in patients with diabetes mellitus. Cardiovasc Diabetol 14(1):37","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"2613_CR5","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s10554-017-1198-8","volume":"33","author":"Y Mochizuki","year":"2017","unstructured":"Mochizuki Y, Tanaka H, Matsumoto K, Sano H, Shimoura H, Ooka J, Sawa T, Motoji Y, Ryo-Koriyama K, Hirota Y, Ogawa W, Hirata KI (2017) Hirata KI Impact of left ventricular longitudinal functional mechanics on the progression of diastolic function in diabetes mellitus. Int J Cardiovasc Imaging 33(12):1905\u20131914","journal-title":"Int J Cardiovasc Imaging"},{"issue":"1","key":"2613_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s12574-018-0408-2","volume":"17","author":"H Tanaka","year":"2019","unstructured":"Tanaka H (2019) Utility of strain imaging in conjunction with heart failure stage classification for heart failure patient management. J Echocardiogr 17(1):17\u201324","journal-title":"J Echocardiogr"},{"issue":"3","key":"2613_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2337\/diacare.27.3.699","volume":"27","author":"AG Bertoni","year":"2004","unstructured":"Bertoni AG, Hundley WG, Massing MW, Bonds DE, Burke GL, Goff DC Jr (2004) Heart failure prevalence, incidence, and mortality in the elderly with diabetes. Diabetes Care 27(3):699\u2013703","journal-title":"Diabetes Care"},{"issue":"7","key":"2613_CR8","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S2213-8587(16)30057-2","volume":"4","author":"JR Brownrigg","year":"2016","unstructured":"Brownrigg JR, Hughes CO, Burleigh D, Karthikesalingam A, Patterson BO, Holt PJ, Thompson MM, de Lusignan S, Ray KK (2016) Hinchliffe RJ Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study. Lancet Diabetes Endocrinol 4(7):588\u2013597","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"2613_CR9","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.2337\/dc18-2515","volume":"42","author":"J Tromp","year":"2019","unstructured":"Tromp J, Lim SL, Tay WT, Teng TK, Chandramouli C, Ouwerkerk W, Wander GS, Sawhney JPS, Yap J, MacDonald MR, Ling LH, Sattar N, McMurray JJV, Richards AM, Anand I et al (2019) Microvascular disease in patients with diabetes with heart failure and reduced ejection versus preserved ejection fraction. Diabetes Care 42(9):1792\u20131799","journal-title":"Diabetes Care"},{"issue":"4","key":"2613_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jcmg.2014.12.020","volume":"8","author":"MT Jensen","year":"2015","unstructured":"Jensen MT, Sogaard P, Andersen HU, Bech J, Fritz Hansen T, Biering-Sorensen T, Jorgensen PG, Galatius S, Madsen JK, Rossing P, Jensen JS (2015) Global longitudinal strain is not impaired in type 1 diabetes patients without albuminuria: the thousand & 1 study. JACC Cardiovasc Imaging 8(4):400\u2013410","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"2613_CR11","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.2337\/diacare.27.10.2568","volume":"27","author":"W Rathmann","year":"2004","unstructured":"Rathmann W, Giani G (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes care 27(10):2568\u20132569 (author reply 2569)","journal-title":"Diabetes care"},{"issue":"4","key":"2613_CR12","doi-asserted-by":"publisher","first-page":"798","DOI":"10.2337\/diacare.29.04.06.dc05-1433","volume":"29","author":"SS Soedamah-Muthu","year":"2006","unstructured":"Soedamah-Muthu SS, Fuller JH, Mulnier HE, Raleigh VS, Lawrenson RA, Colhoun HM (2006) High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database. Diabetes Care 29(4):798\u2013804","journal-title":"Diabetes Care"},{"issue":"9786","key":"2613_CR13","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0140-6736(11)60471-6","volume":"378","author":"M Lind","year":"2011","unstructured":"Lind M, Bounias I, Olsson M, Gudbjornsdottir S, Svensson AM, Rosengren A (2011) Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study. Lancet 378(9786):140\u2013146","journal-title":"Lancet"},{"issue":"7","key":"2613_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15(7):539\u2013553","journal-title":"Diabet Med"},{"issue":"3","key":"2613_CR15","first-page":"217","volume":"60","author":"HR Martinez-Ramirez","year":"2008","unstructured":"Martinez-Ramirez HR, Cortes-Sanabria L, Rojas-Campos E, Barragan G, Alfaro G, Hernandez M, Canales-Munoz JL, Cueto-Manzano AM (2008) How frequently the clinical practice recommendations for nephropathy are achieved in patients with type 2 diabetes mellitus in a primary health-care setting? Rev Invest Clin 60(3):217\u2013226","journal-title":"Rev Invest Clin"},{"issue":"1","key":"2613_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the american society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr 28(1):1-39e14","journal-title":"J Am Soc Echocardiogr"},{"issue":"3","key":"2613_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1001\/jama.292.3.344","volume":"292","author":"VL Roger","year":"2004","unstructured":"Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, Jacobsen SJ (2004) Trends in heart failure incidence and survival in a community-based population. JAMA 292(3):344\u2013350","journal-title":"JAMA"},{"issue":"12","key":"2613_CR18","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1161\/CIRCULATIONAHA.106.666818","volume":"115","author":"KA Ammar","year":"2007","unstructured":"Ammar KA, Jacobsen SJ, Mahoney DW, Kors JA, Redfield MM, Burnett JC Jr, Rodeheffer RJ (2007) Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology\/American Heart Association heart failure staging criteria in the community. Circulation 115(12):1563\u20131570","journal-title":"Circulation"},{"issue":"9","key":"2613_CR19","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.jcmg.2017.07.001","volume":"10","author":"PP Sengupta","year":"2017","unstructured":"Sengupta PP, Kramer CM, Narula J, Dilsizian V (2017) The potential of clinical phenotyping of heart failure with imaging biomarkers for guiding therapies: a focused update. JACC Cardiovasc Imaging 10(9):1056\u20131071","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"2613_CR20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.2337\/diacare.26.3.855","volume":"26","author":"L Vaur","year":"2003","unstructured":"Vaur L, Gueret P, Lievre M, Chabaud S, Passa P (2003) study DSG Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) study. Diabetes Care 26(3):855\u2013860","journal-title":"Diabetes Care"},{"issue":"22","key":"2613_CR21","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1161\/01.CIR.103.22.2668","volume":"103","author":"C Iribarren","year":"2001","unstructured":"Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, Selby JV (2001) Glycemic control and heart failure among adult patients with diabetes. Circulation 103(22):2668\u20132673","journal-title":"Circulation"},{"issue":"3","key":"2613_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ihj.2019.04.008","volume":"71","author":"I Zairi","year":"2019","unstructured":"Zairi I, Mzoughi K, Kamoun S, Moussa FB, Rezgallah R, Maatoug J, Mazigh S, Kraiem S (2019) Impairment of left and right ventricular longitudinal strain in asymptomatic children with type 1 diabetes. Indian Heart J 71(3):249\u2013255","journal-title":"Indian Heart J"},{"key":"2613_CR23","doi-asserted-by":"publisher","first-page":"858746","DOI":"10.1155\/2013\/858746","volume":"2013","author":"W Jia","year":"2013","unstructured":"Jia W, Xu A, Chen A, Wu J, Ye J (2013) Chronic vascular complications in diabetes. J Diabetes Res 2013:858746","journal-title":"J Diabetes Res"},{"issue":"19","key":"2613_CR24","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","volume":"52","author":"C Ronco","year":"2008","unstructured":"Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52(19):1527\u20131539","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2613_CR25","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.2337\/db08-1543","volume":"58","author":"PH Groop","year":"2009","unstructured":"Groop PH, Thomas MC, Moran JL, Waden J, Thorn LM, Makinen VP, Rosengard-Barlund M, Saraheimo M, Hietala K, Heikkila O, Forsblom C, FinnDiane Study G (2009) The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes. Diabetes 58(7):1651\u20131658","journal-title":"Diabetes"},{"issue":"11","key":"2613_CR26","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1007\/s00125-013-3025-7","volume":"56","author":"ME Jorgensen","year":"2013","unstructured":"Jorgensen ME, Almdal TP, Carstensen B (2013) Time trends in mortality rates in type 1 diabetes from 2002 to 2011. Diabetologia 56(11):2401\u20132404","journal-title":"Diabetologia"},{"issue":"11","key":"2613_CR27","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1007\/s00125-010-1860-3","volume":"53","author":"TJ Orchard","year":"2010","unstructured":"Orchard TJ, Secrest AM, Miller RG, Costacou T (2010) In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetologia 53(11):2312\u20132319","journal-title":"Diabetologia"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-022-02613-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-022-02613-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-022-02613-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T17:32:00Z","timestamp":1695144720000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-022-02613-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,23]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["2613"],"URL":"https:\/\/doi.org\/10.1007\/s10554-022-02613-z","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,23]]},"assertion":[{"value":"16 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Hidekazu Tanaka is a consultant for AstraZeneca plc and Ono Pharmaceutical Company, Limited. Yushi Hirota is a consultant for Eli Lilly and Company. Wataru Ogawa is a consultant for Sumitomo Dainippon Pharma Co., Ltd. Wataru Ogawa has received research funding from Sumitomo Dainippon Pharma Co., Ltd., Boehringer Ingelheim, Eli Lilly and Company, Novo Nordisk A\/S, TEIJIN PHARMA LIMITED., and Takeda Pharmaceutical Company Limited. Ken-ichi Hirata has received research funding from Daiichi Sankyo Company, Limited, Actelion Pharmaceuticals Japan, Terumo Corporation, Abbott Vascular Japan, Otsuka Pharmaceutical Company, Limited, Kowa Company, Limited, Takeda Pharmaceutical Company Limited, Nihon Medi-Physics Company Limited, Novartis Pharma Company Limited, Bayer Company Limited, Biotronic Japan Company Limited, FUJIFILM Toyama Chemical Company Limited, Medtronic Japan Company Limited, Sysmex Company Limited. The remaining authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}